ivabradine has been researched along with atenolol in 25 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (atenolol) | Trials (atenolol) | Recent Studies (post-2010) (atenolol) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 5,473 | 1,950 | 852 |
| Protein | Taxonomy | ivabradine (IC50) | atenolol (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.7468 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (52.00) | 29.6817 |
| 2010's | 11 (44.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berdeaux, A; Colin, P; Ghaleh, B; Giudicelli, JF; Hittinger, L; Monnet, X; Slama, M | 1 |
| Berdeaux, A; Colin, P; Ghaleh, B; Giudicelli, JF; Hittinger, L; Monnet, X; Su, J | 1 |
| Berdeaux, A; Colin, P; Ghaleh, B; Giudicelli, JF; Hittinger, L; Monnet, X | 1 |
| Bourassa, MG; Ford, I; Fox, K; Tardif, JC; Tendera, M | 1 |
| Berdeaux, A; Bizé, A; Colin, P; Ghaleh, B; Lucats, L; Monnet, X | 2 |
| Biriuchenko, MV; Pozdniakova, NV; Tatarchenko, IP | 1 |
| Füessl, HS | 1 |
| van de Borne, P | 1 |
| Kahan, T; Ponikowski, P; Tardif, JC | 2 |
| Sajadieh, A | 1 |
| de Silva, R; Fox, KM | 1 |
| Campanelli, JJ; Christensen, LP; Dedkov, EI; Tomanek, RJ; Weiss, RM; Zhang, RL; Zheng, W | 1 |
| Christensen, LP; Tomanek, RJ; Zhang, RL | 1 |
| Massé, JF | 1 |
| Chaturvedi, V; Kurian, S; Parakh, N; Tyagi, S | 1 |
| Bonagura, JD; Cervenec, RM; Riesen, SC; Schober, KE | 1 |
| Crea, F; Di Franco, A; Ghirlanda, G; Lanza, GA; Milo, M; Nerla, R; Pitocco, D; Russo, G; Sarullo, FM; Stazi, A; Tarzia, P; Villano, A; Zaccardi, F | 1 |
| Benvenuto, A; Masciocco, L; Prencipe, G; Riccioni, G; Rizzo, U; Russi, C; Speziale, G; Ventra, S | 1 |
| Kiiakbaev, GK; Kobalava, ZhD; Shavarov, AA | 1 |
| Jia, Y; Jiang, J; Jiang, R; Jing, L; Li, T; Li, X; Li, Y; Liu, S; Lu, Q; Shou, X; Wang, L; Wang, X; Wang, Z; Wei, J; Xia, H; Xie, P; Xing, B; Yang, Z | 1 |
| Aboshabana, R; Ibrahim, FA; Zeid, AM | 1 |
1 review(s) available for ivabradine and atenolol
| Article | Year |
|---|---|
[What are the alternatives to betablockers in 2009?].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiomyopathies; Heart Failure; Heart Valve Diseases; Humans; Ivabradine; Myocardial Infarction; Myocardial Ischemia; Patient Selection; Stereoisomerism; Vasodilator Agents | 2008 |
10 trial(s) available for ivabradine and atenolol
| Article | Year |
|---|---|
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Exercise Tolerance; Female; Heart Conduction System; Humans; Ion Channels; Ivabradine; Male; Middle Aged | 2005 |
[Comparative efficacy of ivabradine and atenolol in correction of clinical and functional parameters in patients with stable effort angina].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Benzazepines; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Ivabradine; Male; Stereoisomerism; Treatment Outcome | 2008 |
Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Benzazepines; Blood Pressure; Cardiovascular Agents; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Ion Channels; Ivabradine; Male; Middle Aged; Sinoatrial Node; Treatment Outcome; Young Adult | 2009 |
Effect of ivabradine vs atenolol on heart rate and effort tolerance in patients with mild to moderate mitral stenosis and normal sinus rhythm.
Topics: Adolescent; Adult; Aged; Atenolol; Benzazepines; Cross-Over Studies; Electrocardiography, Ambulatory; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Mitral Valve Stenosis; Stimulation, Chemical; Ultrasonography, Doppler; Young Adult | 2012 |
Effects of treatment with ivabradine and atenolol on reproducibility of echocardiographic indices of left heart size and function in healthy cats.
Topics: Animals; Atenolol; Atrial Function, Left; Benzazepines; Cardiovascular Agents; Cats; Double-Blind Method; Echocardiography; Female; Heart Atria; Heart Rate; Heart Ventricles; Ivabradine; Reproducibility of Results; Ventricular Function, Left | 2012 |
Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients.
Topics: Atenolol; Benzazepines; Brachial Artery; Cardiovascular Diseases; Cyclic Nucleotide-Gated Cation Channels; Diabetes Mellitus, Type 2; Double-Blind Method; Electrocardiography; Endothelium, Vascular; Female; Follow-Up Studies; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prospective Studies; Sympathetic Nervous System; Sympatholytics; Vasodilation | 2012 |
Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Atenolol; Benzazepines; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Treatment Outcome | 2013 |
Ivabradine improves all aspects of quality of life assessed with the 36-item short form health survey in subjects with chronic ischemic heart disease compared with beta-blockers.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Atenolol; Benzazepines; Bisoprolol; Carbazoles; Carvedilol; Female; Health Surveys; Humans; Ivabradine; Male; Middle Aged; Propanolamines; Quality of Life | 2013 |
[A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris].
Topics: Aged; Angina, Stable; Anti-Arrhythmia Agents; Atenolol; Benzazepines; Drug Therapy, Combination; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Research Design; Treatment Outcome | 2013 |
The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris.
Topics: Adult; Aged; Angina, Stable; Atenolol; Benzazepines; Blood Pressure; China; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2014 |
14 other study(ies) available for ivabradine and atenolol
| Article | Year |
|---|---|
Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzazepines; Blood Pressure; Cardiotonic Agents; Consciousness; Dogs; Heart Rate; Ivabradine; Myocardial Contraction; Physical Exertion; Ventricular Function, Left; Ventricular Pressure | 2002 |
Contributions of heart rate and contractility to myocardial oxygen balance during exercise.
Topics: Animals; Anti-Arrhythmia Agents; Atenolol; Benzazepines; Cardiac Pacing, Artificial; Dogs; Heart Rate; Hemodynamics; Ivabradine; Motor Activity; Myocardial Contraction; Myocardium; Oxygen Consumption; Stroke Volume; Ventricular Function, Left | 2003 |
Heart rate reduction during exercise-induced myocardial ischaemia and stunning.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Atenolol; Benzazepines; Blood Pressure; Constriction; Coronary Circulation; Dogs; Heart Rate; Ivabradine; Myocardial Ischemia; Myocardial Stunning; Physical Exertion; Ventricular Function, Left | 2004 |
Heart rate reduction by inhibition of If or by beta-blockade has different effects on postsystolic wall thickening.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzazepines; Cardiovascular Agents; Dogs; Heart Rate; Heart Ventricles; Ivabradine; Myocardium; Physical Conditioning, Animal | 2007 |
Conversion of post-systolic wall thickening into ejectional thickening by selective heart rate reduction during myocardial stunning.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzazepines; Blood Pressure; Dogs; Heart Atria; Heart Rate; Ivabradine; Myocardial Contraction; Myocardial Stunning; Stroke Volume; Systole | 2007 |
[Resting heart rate as prognostic parameter--a slow rate indicates strength].
Topics: Adrenergic beta-Antagonists; Atenolol; Benzazepines; Coronary Disease; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Heart Rate; Humans; Ivabradine; Multicenter Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Rest; Stroke; Survival Rate | 2008 |
A new combination therapy in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Drug Therapy, Combination; Humans; Ivabradine; Treatment Outcome | 2009 |
Angina: Ivabradine for treatment of stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Benzazepines; Chronic Disease; Drug Therapy, Combination; Exercise Tolerance; Heart Rate; Humans; Ivabradine; Treatment Outcome | 2009 |
Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Atenolol; Benzazepines; Bradykinin; Cardiotonic Agents; Collagen; Coronary Circulation; Electrocardiography; Heart Rate; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Ivabradine; Male; Myocardial Infarction; Neovascularization, Physiologic; Organ Size; Perfusion; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Ventricular Remodeling | 2009 |
Chronic heart rate reduction facilitates cardiomyocyte survival after myocardial infarction.
Topics: Animals; Anti-Arrhythmia Agents; Atenolol; Benzazepines; Bradycardia; Cell Survival; Cicatrix; Coronary Circulation; Diastole; Disease Models, Animal; Heart Rate; Ivabradine; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Recovery of Function; Regeneration; Treatment Outcome | 2010 |
Stable angina: role of ivabradine unchanged between 2006 and 2010.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Drug Therapy, Combination; Humans; Ivabradine; Randomized Controlled Trials as Topic | 2010 |
[Symptomatic coronary heart disease. Therapy with a beta blocker and ivabradine combination].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Coronary Disease; Drug Therapy, Combination; Guideline Adherence; Heart Failure; Humans; Ivabradine; Survival Rate | 2014 |
[Symptomatic coronary heart diseases. Combination therapy is successful in general practice].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Clinical Trials as Topic; Coronary Disease; Drug Combinations; Heart Rate; Humans; Ivabradine | 2014 |
Label-free green estimation of atenolol and ivabradine hydrochloride in pharmaceutical and biological matrices by synchronous spectrofluorimetry.
Topics: Atenolol; Ethanol; Humans; Ivabradine; Pharmaceutical Preparations; Solvents; Spectrometry, Fluorescence | 2023 |